| Younger group (n = 20) | Older group (n = 46) | P |
---|---|---|---|
VD of SCP (Whole Image) | |||
 Baseline | 42.6 ± 3.4 | 40.4 ± 4.8 | 0.112 |
 3 months after treatment | 42.9 ± 4.7 | 39.3 ± 4.5 | 0.007* |
 12 months after treatment | 43.8 ± 5.0 | 40.3 ± 3.4 | 0.005* |
VD of SCP (ParaFovea) | |||
 Baseline | 44.9 ± 4.1 | 42.4 ± 5.1 | 0.089 |
 3 months after treatment | 44.8 ± 5.0 | 41.4 ± 4.8 | 0.017* |
 12 months after treatment | 46.0 ± 5.7 | 42.4 ± 3.9 | 0.010* |
VD of DCP (Whole Image) | |||
 Baseline | 42.9 ± 4.4 | 41.4 ± 5.2 | 0.312 |
 3 months after treatment | 42.6 ± 5.5 | 40.7 ± 5.9 | 0.253 |
 12 months after treatment | 45.8 ± 5.0 | 42.1 ± 4.4 | 0.011* |
VD of DCP (ParaFovea) | |||
 Baseline | 44.3 ± 4.9 | 43.4 ± 5.7 | 0.561 |
 3 months after treatment | 44.0 ± 6.2 | 42.8 ± 6.1 | 0.493 |
 12 months after treatment | 46.9 ± 5.4 | 44.2 ± 5.0 | 0.090 |
FAZ size | |||
 Baseline | 0.33 ± 0.13 | 0.41 ± 0.22 | 0.168 |
 3 months after treatment | 0.33 ± 0.13 | 0.42 ± 0.16 | 0.036* |
 12 months after treatment | 0.34 ± 0.14 | 0.47 ± 0.18 | 0.012* |
FAZ perimeter | |||
 Baseline | 2.35 ± 0.48 | 2.70 ± 0.79 | 0.094 |
 3 months after treatment | 2.39 ± 0.41 | 2.76 ± 0.62 | 0.027* |
 12 months after treatment | 2.30 ± 0.70 | 2.95 ± 0.72 | 0.004* |